Automatic sensitivity control for a pacemaker

• US 4,708,144 A
• Filed: 10/06/1986
• Issued: 11/24/1987
• Est. Priority Date: 10/06/1986
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Telectronics Incorporated
• Inventors: Hamilton, John R., Whigham, Robert H.
• Primary Examiner(s): NOT, DEFINED
• Assistant Examiner(s): NOT, DEFINED
• Application Number:
  US06/915,694
• Time in Patent Office: 414 Days
• Field of Search: 128/419 P, 128/695, 128/696, 128/901, 128/419 PT, 128/419 PG, 330/284, 330/144, 330/145
• US Class Current: 607/9
• CPC Class Codes: A61B 5/349 Detecting specific parameters of the electrocardiograph cycle
• CPC Class Codes: A61B 5/7203 for noise prevention, reduction or removal
• CPC Class Codes: A61B 5/7207 of noise induced by motion artifacts
• CPC Class Codes: A61N 1/3704 Circuits specially adapted therefor, e.g. for sensitivity control
• CPC Class Codes: Y10S 128/901 Suppression of noise in electric signal

Abstract

An implantable pacemaker in which the sensitivity is automatically controlled. The peak value of each R wave is measured, and a long-term average is derived. The gain of the sense channel is adjusted automatically in accordance with the average of the measured peak values.

Claims

1. An automatic sensitivity control for an implantable pacemaker comprising means for sensing a cardiac signal, means for amplifying said cardiac signal, means for comparing the amplified cardiac signal with a threshold value for determining the occurrence of a cardiac event, means for measuring the peak amplitude of said amplified cardiac signal for the determined cardiac event, means for deriving a value representative of the average of the measured peak amplitudes during a preceding time interval which is at least a few minutes long, and means for varying the gain of said amplifying means in accordance with said derived value.

2. An automatic sensitivity control for an implantable pacemaker in accordance with claim 1 wherein said value deriving means including means for sensing the presence of noise during a cardiac cycle and for excluding from the derived value any measured peak amplitude for a cardiac event which occurs during a cardiac cycle which contains noise exceeding a predetermined level.

3. An automatic sensitivity control for an implantable pacemaker in accordance with claim 1 wherein said comparing means, said measuring means and said value deriving means all operate digitally.

4. An automatic sensitivity control for an implantable pacemaker in accordance with claim 1 wherein said value deriving means includes means for delaying the derivation of said value following the determination of the occurrence of a cardiac event for a predetermined interval to ensure that the peak amplitude of such cardiac event is measured.

5. An automatic sensitivity control for an implantable pacemaker in accordance with claim 1 wherein said amplifying means includes an amplifier having a gain greater than unity and a connected attenuator whose degree of attenuation is controlled in accordance with the magnitude of said derived value.

6. An automatic sensitivity control for an implantable pacemaker in accordance with claim 1 wherein said amplifying means, said comparing means, said measuring means and said varying means are dedicated digital circuits, and said value deriving means is a microprocessor which halts its operation between cardiac events.

7. A method for improving the determination of the occurrence of a cardiac event comprising the steps of sensing a cardiac signal, amplifying said cardiac signal, comparing the amplified cardiac signal with a threshold value for determining the occurrence of a cardiac event, deriving a value representative of the average of the measured peak amplitudes during a preceding time interval which is at least a few minutes long, and varying the gain of said amplifying means in accordance with said derived value.

8. A method in accordance with claim 7 wherein in said value deriving step the presence of noise is sensed during a cardiac cycle and any measured peak amplitude for a cardiac event which occurs during a cardiac cycle which contains noise exceeding a predetermined level is excluded from the derived value.

9. A method in accordance with claim 7 wherein said comparing step, said measuring step and said value deriving step are all implemented digitally.

10. A method in accordance with claim 7 wherein the performance of said value deriving step is delayed following the determination of the occurrence of a cardiac event for a predetermined interval to ensure that the peak amplitude of such cardiac event is measured.